REBgold Extends Terms of Convertible Debentures and Warrants

REBgold Corporation ("REBgold" or the "Company")(TSX VENTURE:RBG) announced
today that it has extended the expiry date of $410,000 principal amount of the
Company's current outstanding 18% unsecured convertible debentures (the
"Debentures") and 4,100,000 of the common share purchase warrants (the
"Warrants") originally issued in October 2010. $430,000 principal amount of
Debentures and 4,300,000 Warrants were originally issued in October 2010. The
original maturity date of the Debentures, and the original expiry date of the
Warrants, was October 13, 2011. In October 2011 the expiry date of $410,000
principal amount of Debentures and 4,100,000 of the Warrants was extended to
April 13, 2012. Each holder of Debentures and Warrants was offered the choice to
either (i) further extend the maturity date of the Debentures held by that
holder to April 13, 2015, in which case the expiry date of the Warrants held by
that holder would also be extended to April 13, 2015, or (ii) accept payment in
full of the Debentures on April 13, 2012, in which case the Warrants held by
that holder would also expire on April 13, 2012. All of the holders of the
currently outstanding Debentures and Warrants elected to extend the expiry date
to April 13, 2015.


As a result of the corporate reorganization by Plan of Arrangement which was
completed effective December 2, 2010 involving the Company and BacTech
Environmental Corporation ("BacTech Environmental"), the Debentures are
convertible into units (the "Units") comprised of one common share of the
Company and one-fifth of a common share of BacTech Environmental, at a
conversion price of $0.10 per Unit. The Warrants are exercisable for Units at a
price of $0.12 per Unit. The conversion price of the Debentures and the exercise
price of the Warrants remain unchanged. The TSX Venture Exchange has accepted
notice of the extension of the terms of the Debentures and the Warrants.


REBgold PROFILE

REBgold is in the process of acquiring and developing economic interests in gold
assets, in particular, where it can utilize its competitive advantages, to
create shareholder value.


The Company's key competitive advantages include an experienced board and
management team, strategic investor backing and proprietary technology. The
Company's bacterial oxidation and bioleaching technologies are commercially
proven for the liberation of precious metals from difficult-to-treat sulphide
ores and concentrates, with environmental and economic benefits. To date, the
Company's BACOX technology has been used at three gold mines located in Western
Australia, Tasmania and China.


Shares outstanding 182,258,486